Items where Author is "Feghali-Bostwick, CA"

Magee, KE and Kelsey, CE and Kurzinski, KL and Ho, J and Mlakar, LR and Feghali-Bostwick, CA and Torok, KS (2013) Interferon-gamma inducible protein-10 as a potential biomarker in localized scleroderma. Arthritis Research and Therapy, 15 (6). ISSN 1478-6354

Aida-Yasuoka, K and Peoples, C and Yasuoka, H and Hershberger, P and Thiel, K and Cauley, JA and Medsger, TA and Feghali-Bostwick, CA (2013) Estradiol promotes the development of a fibrotic phenotype and is increased in the serum of patients with systemic sclerosis. Arthritis Research and Therapy, 15 (1). ISSN 1478-6354

Ruiz, XD and Mlakar, LR and Yamaguchi, Y and Su, Y and Larregina, AT and Pilewski, JM and Feghali-Bostwick, CA (2012) Syndecan-2 is a novel target of insulin-like growth factor binding protein-3 and is over-expressed in fibrosis. PLoS ONE, 7 (8).

Xue, J and Gochuico, BR and Alawad, AS and Feghali-Bostwick, CA and Noth, I and Nathan, SD and Rosen, GD and Rosas, IO and Dacic, S and Ocak, I and Fuhrman, CR and Cuenco, KT and Smith, MA and Jacobs, SS and Zeevi, A and Morel, PA and Pilewski, JM and Valentine, VG and Gibson, KF and Kaminski, N and Sciurba, FC and Zhang, Y and Duncan, SR (2011) The HLA class II allele DRB1*1501 is over-represented in patients with idiopathic pulmonary fibrosis. PLoS ONE, 6 (2).